Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Medtronic
Johnson and Johnson
Citi
QuintilesIMS
Julphar
Federal Trade Commission
Baxter
Mallinckrodt

Generated: June 25, 2018

DrugPatentWatch Database Preview

Adefovir dipivoxil - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for adefovir dipivoxil and what is the scope of adefovir dipivoxil patent protection?

Adefovir dipivoxil
is the generic ingredient in two branded drugs marketed by Sigmapharm Labs Llc and Gilead, and is included in two NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Adefovir dipivoxil has sixty-four patent family members in twenty-five countries.

There are eight drug master file entries for adefovir dipivoxil. Three suppliers are listed for this compound.
Synonyms for adefovir dipivoxil
((((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate)
(((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate
(((2-(6-AMINO-9H-PURIN-9-YL)ETHOXY)METHYL)PHOSPHORYL)BIS(OXY)BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE)
((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate
(2-(6-AMINOPURIN-9-YL)ETHOXYMETHYL-(2,2-DIMETHYLPROPANOYLOXYMETHOXY)PHOSPHORYL)OXYMETHYL2,2-DIMETHYLPROPANOATE
[({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate
[2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate
142340-99-6
2,2-dimethylpropanoic acid [2-(6-aminopurin-9-yl)ethoxymethyl-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3-phosphanon-1-yl pivalate (non-preferred
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3?5-phosphanon-1-yl 2,2-dimethylpropanoate
3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3lambda~5~-phosphanon-1-yl 2,2-dimethylpropanoate
340A996
9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine
9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine
9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine
9-[2-[BIS[(PIVALOYLOXY)METHOXY]PHOSPHINYL]METHOXY]ETHYL]ADENINE
A807894
AB0012816
AB01274706_02
AB01274706-01
AB07592
AB2000245
AC-1693
AC1L1U36
adefovir depivoxil
Adefovir di(pivaloyloxymethyl) ester
Adefovir Dipivoxil (Preveon, Hepsera)
Adefovir dipivoxil (USAN)
Adefovir dipivoxil [USAN]
Adefovir dipivoxil, Antibiotic for Culture Media Use Only
Adefovir dipivoxyl
Adefovir pivoxil
Adefovir pivoxil (JAN)
Adefovirdipivoxl
AKOS005145737
Ambap142340-99-6
AN-6719
ANW-43238
API0001387
ARONIS27063
B2222
BC206225
BCP0726000157
BCP9000232
BCPP000434
bis-POM PMEA
Bis-POM PMEA, Adefovir Dipivoxil
Bis-POM PMEA, Preveon, Hepsera, Adefovir Dipivoxil
Bis-POM PMEA;Preveon;Hepsera;Preveon;Hepsera
Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine
BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE
Bis(POM)-PMEA
Bis(pom)PMEA
C-22950
C20H32N5O8P
CA0117
CAS-142340-99-6
CC-23770
CHEMBL922
CS-2240
CTK8B3813
D01655
D0ML1F
DB00718
DIPIVOXIL
DR003071
DSSTox_CID_26487
DSSTox_GSID_46487
DSSTox_RID_81658
DTXSID5046487
FT-0082875
FT-0631164
GP5823
GS 0840
GS 840
GS-0840
GS-3604
GS-840
HE310667
Hepsera
Hepsera (TM)
Hepsera (TN)
HMS3604F09
HMS3655I04
HY-B0255
I06-1150
I14-3234
KS-00000L27
KS-000048K6
LS-173141
MCULE-6257358029
MFCD00869897
MLS003915635
MLS004774124
NCGC00164624-01
NCGC00164624-02
NCGC00164624-03
Piv2PMEA
Preveon
Preveon (TN)
Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester
Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester
PubChem14224
Q-101927
RP17773
RTC-070886
s1718
SCHEMBL29729
SMR002530072
SR-01000931258
SR-01000931258-2
STL257088
TC-070886
TL8000938
Tox21_112243
Tox21_112243_1
U6Q8Z01514
UNII-U6Q8Z01514
W-2203
YouHeDing
ZINC3930376

US Patents and Regulatory Information for adefovir dipivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Sigmapharm Labs Llc ADEFOVIR DIPIVOXIL adefovir dipivoxil TABLET;ORAL 202051-001 Aug 29, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for adefovir dipivoxil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Gilead HEPSERA adefovir dipivoxil TABLET;ORAL 021449-001 Sep 20, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for adefovir dipivoxil

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00131 Netherlands ➤ Sign Up PRODUCT NAME: ADEFOVIR DIPIVOXIL, DESGEWENST IN DE VORM VAN FARMACEUTISCH AANVAARDBARE ZUURADDITIE ZOUTEN, METAALZOUTEN EN SOLVATEN HIERVAN; NAT. REGISTRATION NO/DATE: EU/1/03/251/001 20030306; FIRST REGISTRATION: EU/1/03/251/001 20030306
C0034 France ➤ Sign Up PRODUCT NAME: ADEFOVIR DIPIVOXIL; REGISTRATION NO/DATE: EU/1/03/251/001 20030306
C/GB03/030 United Kingdom ➤ Sign Up PRODUCT NAME: ADEFOVIR DIPIVOXIL; REGISTERED: UK EU/1/03/251/001 20030306
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Johnson and Johnson
AstraZeneca
Harvard Business School
Federal Trade Commission
Deloitte
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.